Cancer nanotechnology: a new approach to upgrade cancer diagnosis and therapy

Rad, DM; Nazari, H; Naei, VY; Lotfi, M; Aref, AR; Warkiani, ME

Cancer nanotechnology: a new approach to upgrade cancer diagnosis and therapy

Rad, DM Nazari, H Naei, VY Lotfi, M Aref, AR Warkiani, ME

Permalink

Publisher:: Elsevier
Publication Type:: Chapter
Citation:: Functionalized Nanomaterials for Cancer Research: Applications in Treatments, Tools and Devices, 2024, pp. 37-62
Issue Date:: 2024-01-01

Closed Access

	Filename	Description	Size
	23090157_14936352300005671.pdf	Published version	3.15 MB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Rad, DM
dc.contributor.author	Nazari, H
dc.contributor.author	Naei, VY
dc.contributor.author	Lotfi, M
dc.contributor.author	Aref, AR
dc.contributor.author	Warkiani, ME
dc.date.accessioned	2024-09-10T00:50:31Z
dc.date.available	2024-09-10T00:50:31Z
dc.date.issued	2024-01-01
dc.identifier.citation	Functionalized Nanomaterials for Cancer Research: Applications in Treatments, Tools and Devices, 2024, pp. 37-62
dc.identifier.isbn	9780443155185
dc.identifier.uri	http://hdl.handle.net/10453/180766
dc.description.abstract	Cancer is among the leading causes of mortality worldwide. Although different diagnostic and therapeutic approaches have been implemented for cancer management and reducing the mortality rate, the limitations attributed to these strategies have hampered the improvements in prognosis and overall survival of cancer patients. Early detection and an appropriate therapeutic strategy are critical steps toward cancer management and successful therapy. Therefore, there is a crucial demand for advanced technologies to bring existing cancer diagnostic and therapeutic approaches to the next level. The emerging field of nanotechnology has involved nanoengineered materials and devices in upgrading the specificity and effectiveness of the current diagnostic and therapeutic strategies. The recent advances in developing nanocarriers and nano biosensors can enhance the sensitivity of detecting biomarkers and cancer cells. Moreover, engineered nanoparticles can increase therapeutic efficacy and diminish the side effects of conventional and novel therapeutic modalities. Theranostic agents are the next generation of multitasking nanoparticles that can detect and attack cancer cells simultaneously. This book chapter provides an insight into the advancement of nanotechnologies assisting early detection and cancer-targeted therapy and highlights the existing challenges in clinical trials and commercial products.
dc.language	en
dc.publisher	Elsevier
dc.relation.ispartof	Functionalized Nanomaterials for Cancer Research: Applications in Treatments, Tools and Devices
dc.relation.isbasedon	10.1016/B978-0-443-15518-5.00013-6
dc.rights	info:eu-repo/semantics/closedAccess
dc.title	Cancer nanotechnology: a new approach to upgrade cancer diagnosis and therapy
dc.type	Chapter
pubs.organisational-group	University of Technology Sydney
pubs.organisational-group	University of Technology Sydney/Faculty of Engineering and Information Technology
pubs.organisational-group	University of Technology Sydney/Strength - CHT - Health Technologies
pubs.organisational-group	University of Technology Sydney/Faculty of Engineering and Information Technology/School of Biomedical Engineering
pubs.organisational-group	University of Technology Sydney/All Manual Groups
pubs.organisational-group	University of Technology Sydney/All Manual Groups/Centre for Health Technologies (CHT)
pubs.organisational-group	University of Technology Sydney/All Manual Groups/Institute of Biomedical Materials and Devices (IBMD)
pubs.organisational-group	University of Technology Sydney/All Manual Groups/Institute of Biomedical Materials and Devices (IBMD)/Associate Member
utslib.copyright.status	closed_access	*
dc.date.updated	2024-09-10T00:50:28Z
pubs.publication-status	Published

Abstract:

Cancer is among the leading causes of mortality worldwide. Although different diagnostic and therapeutic approaches have been implemented for cancer management and reducing the mortality rate, the limitations attributed to these strategies have hampered the improvements in prognosis and overall survival of cancer patients. Early detection and an appropriate therapeutic strategy are critical steps toward cancer management and successful therapy. Therefore, there is a crucial demand for advanced technologies to bring existing cancer diagnostic and therapeutic approaches to the next level. The emerging field of nanotechnology has involved nanoengineered materials and devices in upgrading the specificity and effectiveness of the current diagnostic and therapeutic strategies. The recent advances in developing nanocarriers and nano biosensors can enhance the sensitivity of detecting biomarkers and cancer cells. Moreover, engineered nanoparticles can increase therapeutic efficacy and diminish the side effects of conventional and novel therapeutic modalities. Theranostic agents are the next generation of multitasking nanoparticles that can detect and attack cancer cells simultaneously. This book chapter provides an insight into the advancement of nanotechnologies assisting early detection and cancer-targeted therapy and highlights the existing challenges in clinical trials and commercial products.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/180766